Wormhole, the cross-chain bridge backed by Jump Crypto, is expanding into the Cosmos ecosystem, marking the project’s 11th collaboration with a base-layer blockchain.
“With Wormhole being a major force within the crypto industry, the partnership will be focused on expanding Injective’s network and supporting new dApps built on top of the blockchain moving forward,” said Eric Chen, CEO of Injective Labs, in a statement.
A cross-chain future
As layer 1 blockchains compete to amass total value locked (TVL) and users, investors and builders are increasingly focusing on interoperability solutions.
Popular layer 1, or base-layer, blockchains, such as Ethereum, Avalanche and Solana, cannot easily communicate with each other, meaning assets held on one blockchain are difficult to transfer onto another.
When tokens are bridged through Wormhole’s Portal Bridge, the original token is locked in a smart contract while a new Portal-wrapped version of that token gets minted on the target chain. Then, the wrapped tokens can be traded for tokens native to the target chain and used for decentralized finance (DeFi).
The integration makes Injective the primary gateway for cross-chain native assets from other prominent layer 1 chains to enter the Cosmos universe.
According to its website, Injective’s venture capital backers include Pantera Capital, Hashed and entrepreneur Mark Cuban.
Earlier this month, Wormhole announced that it had partnered with the blockchain Algorand, with Wormhole Foundation director Hendrik Hofstadt citing the chain’s nine-figure TVL as the main reason for the partnership.
According to its website, Wormhole has over $670 million in TVL across its various bridge integrations.
The leader in news and information on cryptocurrency, digital assets and the future of money, CoinDesk is a media outlet that strives for the highest journalistic standards and abides by a strict set of editorial policies. CoinDesk is an independent operating subsidiary of Digital Currency Group, which invests in cryptocurrencies and blockchain startups. As part of their compensation, certain CoinDesk employees, including editorial employees, may receive exposure to DCG equity in the form of stock appreciation rights, which vest over a multi-year period. CoinDesk journalists are not allowed to purchase stock outright in DCG.